IE
VYGR icon

Israel Englander’s Voyager Therapeutics VYGR Stock Holding History

Israel Englander’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-44,800
Closed -$176K – 6453
2025
Q4 		$176K Sell
44,800
-5,500
-11% -$24.3K ﹤0.01% 5502
2025
Q3 		$235K Buy
+50,300
New +$182K ﹤0.01% 5466
2022
Q2 		– Sell
-30,000
Closed -$229K – 7562
2022
Q1 		$229K Buy
+30,000
New +$134K ﹤0.01% 5753

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Israel Englander's VYGR Position: Q2 2026 in Review

Israel Englander increased its Voyager Therapeutics (VYGR) stake by 30% in Q2 2026, buying an estimated $3.85M and bringing the position to 4,442,951 shares worth $15.6M. The position accounts for 0.01% of the portfolio, ranked #1864.

Israel Englander first reported a position in VYGR in Q4 2017 and has held it in 28 quarters since. 135 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.

  • Israel Englander held 4,442,951 shares of Voyager Therapeutics worth $15.6M as of Q2 2026.
  • Israel Englander bought 1,014,380 Voyager Therapeutics shares in Q2 2026, an estimated $3.85M.
  • Voyager Therapeutics made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1864 holding.
  • Israel Englander first reported a position in Voyager Therapeutics in Q4 2017 and has held it in 28 quarters since.
  • 135 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.